Retinopathy of prematurity blindness worldwide: Phenotypes in the third epidemic

Eye and Brain

Volumn 8, Issue , 2016, Pages 31-36

  Quinn, Graham E ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Blindness; International; ROP

Indexed keywords

ARTICLE; BIRTH WEIGHT; BLINDNESS; DISEASE SEVERITY; EPIDEMIC; GESTATIONAL AGE; HUMAN; INCIDENCE; NEWBORN CARE; PHENOTYPE; PRACTICE GUIDELINE; PREMATURITY; RETROLENTAL FIBROPLASIA; VERY LOW BIRTH WEIGHT;

EID: 84978379640     PISSN: 11792744     EISSN: None     Source Type: Journal    
DOI: 10.2147/EB.S94436     Document Type: Article

References (19)

1. WHO. Global Initiative for the Elimination of Avoidable Blindness. WHO, Geneva; 1997. WHO/PBL/9761.
2. Early Treatment for Retinopathy Of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121:1684-1694.
3. Lawn JE, Davidge R, Paul VK, et al. Born too soon: care for the preterm baby. Reprod Health. 2013;10(Suppl 1):S5.
4. Rahi JS, Cable N. Severe visual impairment and blindness in children in the UK. Lancet. 2003;362:1359-1365.
5. Good WV. Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc. 2004; 102:233-248.
6. Gilbert C, Fielder A, Gordillo L, et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics. 2005;115:e518-e525.
7. Zin A, Gole GA. Retinopathy of prematurity-incidence today. Clin Perinatol. 2013;40:185-200.
8. Zin AA, Magluta C, Pinto MF, et al. Retinopathy of prematurity screening and treatment cost in Brazil. Rev Panam Salud Publica. 2014; 36:37-43.
9. Cross CW. Cost of preventing retrolental fibroplasia. Lancet. 1973;2: 954-956.
10. Lucey JF, Dangman B. A reexamination of the role of oxygen in retrolental fibroplasia. Pediatrics. 1984;73:82-96.
11. Blencowe H, Lawn JE, Vazquez T, et al. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res. 2013;74(Suppl 1):35-49.
12. Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev. 2008;84:77-82.
13. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Incidence and early course of retinopathy of prematurity. Ophthalmology. 1991;98:1628-1640.
14. Quinn G, Johnson L, Abbasi S. Onset of retinopathy of prematurity as related to postnatal and postconceptional age. Br J Ophthalmol. 1992;76:284-288.
15. Reynolds JD, Dobson V, Quinn GE, et al. Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol. 2002;120: 1470-1476.
16. Wilkinson AR, Haines L, Head K, et al. UK retinopathy of prematurity guideline. Early Hum Dev. 2008;84:71-74.
17. Fierson WM. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2013;131:189-195.
18. Zin AA, Moreira ME, Bunce C, et al. Retinopathy of prematurity in 7 neonatal units in Rio de Janeiro: screening criteria and workload implications. Pediatrics. 2010;126:e410-e417.
19. Gordillo L, Villanueva AM, Quinn GE. A practical method for reducing blindness due to retinopathy of prematurity in a developing country. J Perinat Med. 2012;40:577-582.